They redefine our understanding of the role of mitochondria in shaping the unique functionality of the CD4+ and CD8+ T cells in regulating in vivo adaptive immune responses, such as GVHD and antitumor effects, and offer potential avenues for therapeutic interventions in T cell–mediated immunity. The gene discussed is CD4; the disease is graft versus host disease.